Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
Kyou Ho Lee, Eui Chun Kang, Hyoung Jun Koh
Korean J Ophthalmol. 2017;31(2):108-114.   Published online 2017 Mar 21     DOI: https://doi.org/10.3341/kjo.2017.31.2.108
Citations to this article as recorded by Crossref logo
Predictors of Dexamethasone Response of Residual Edema by Branch Retinal Vein Occlusion after Bevacizumab Injection
Jong Bin Lee, Hyun Yeon Kim, Yun Young Kim, Geun Woo Lee
Journal of the Korean Ophthalmological Society.2022; 63(4): 370.     CrossRef
Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: A systematic review and meta-analysis
Qiongzhen Yuan, Yunxia Gao, Yilin Liu, Hanyue Xu, Tong Wang, Ming Zhang
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Comparison of Ranibizumab versus Aflibercept in Treating Macular Edema among Patients with Serous Retinal Detachment Secondary to Branch Retinal Vein Occlusion
Bekir Küçük, Ender Sirakaya, Cagatay Karaca
Ocular Immunology and Inflammation.2021; 29(2): 403.     CrossRef
Noninvasive monitoring of suprachoroidal, subretinal, and intravitreal implants using confocal scanning laser ophthalmoscope (cSLO) and optical coherence tomography (OCT)
Madhoosudan A. Patil, Uday B. Kompella
International Journal of Pharmaceutics.2021; 606: 120887.     CrossRef
Predictive Factors for a Favorable Response to Intravitreal Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
Hyun Goo Kang, Yuri Seo, Eun Young Choi, Sung Chul Lee, Min Kim
Journal of Retina.2018; 3(1): 20.     CrossRef